Header Logo

Connection

SUSAN BLANEY to Furans

Back to Details
This is a "connection" page, showing publications SUSAN BLANEY has written about Furans.
SUSAN BLANEY
Connection Strength
0.605
Furans
  1. A phase 1 study of eribulin mesylate (E7389), a novel microtubule-targeting chemotherapeutic agent, in children with refractory or recurrent solid tumors: A Children's Oncology Group Phase 1 Consortium study (ADVL1314). Pediatr Blood Cancer. 2018 08; 65(8):e27066.
    View in: PubMed
    Score: 0.605
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.